Skip to main content

Animations

MJFF Publications

3821 - 3830 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Stability of motor-nonmotor subtype in early-stage Parkinson’s disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.1040405
    Citation Count: 2
  • Summary Details
    OPEN
    Title: The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.1036068
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Dementia with Lewy bodies post-mortem brains reveal differentially methylated CpG sites with biomarker potential
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-022-03965-x
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Highly efficient generation of isogenic pluripotent stem cell models using prime editing
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.79208
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.919778
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Druggable transcriptomic pathways revealed in Parkinson’s patient-derived midbrain neurons
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00400-0
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Artificial intelligence-enabled detection and assessment of Parkinson’s disease using nocturnal breathing signals
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-022-01932-x
    Citation Count: 208
  • Summary Details
    OPEN
    Title: Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00395-8
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-022-02491-8
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Prevalence and Incidence of Nonmotor Symptoms in Individuals with and Without Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13533
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.